NASDAQ:DNLI

Denali Therapeutics Stock Forecast

etoro logo Buy DNLI
*Your capital is at risk
$23.64
-0.190 (-0.797%)
At Close: Jul 22, 2026
AI Analysis AI Analysis of DNLI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DNLI to Watchlist?
Some Reasons Why To Add DNLI:
  • Low bankruptcy risk (Altman Z-Score: 3.55)
  • Bullish trend confirmed on both short and long timeframes
  • +63.4% price growth over the last year
PDF

Red day on Wednesday for Denali Therapeutics Inc. stock after losing 0.797%
(Updated on Jul 22, 2026)

Buy candidate since Jul 21, 2026 Loss -0.80%

The Denali Therapeutics Inc. stock price fell by -0.797% on the last day (Wednesday, 22nd Jul 2026) from $23.83 to $23.64. During the last trading day the stock fluctuated 2.09% from a day low at $23.42 to a day high of $23.91. The price has been going up and down for this period, and there has been a -11.43% loss for the last 2 weeks. Volume has increased on the last day by 192 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $30.30 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $23.15 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 36.61% during the next 3 months and, with a 90% probability hold a price between $31.62 and $38.70 at the end of this 3-month period.

DNLI Signals & Forecast

A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -13.12%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Denali Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $23.15 and $23.45. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Denali Therapeutics Inc. stock

Denali Therapeutics Inc. finds support from accumulated volume at $22.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.490 between high and low, or 2.09%. For the last week, the stock has had daily average volatility of 4.15%.

Our recommended stop-loss: $22.41 (-5.22%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (DNLI) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Denali Therapeutics Inc. to open at $23.66, and during the day (based on 14 day Average True Range), to move between $23.01 and $24.27, which gives a possible trading interval of +/-$1.26 (+/-5.49%) up or down from last closing price. If Denali Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $22.65 (4.19%) than the resistance at $25.57 (8.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Denali Therapeutics Inc. stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 2.553 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 23, 2026 - $23.66 ( 0.0705%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DNLI Performance

Trading levels for DNLI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 24.15 2.14%
R2 23.96 1.35%
R1 23.84 0.86%
Price 23.64
S1 23.47 -0.721%
S2 23.35 -1.21%
S3 23.17 -2.00%

Accumulated Volume Support & Resistance Levels

Level Price
R3 25.89 9.52%
R2 25.72 8.80%
R1 25.57 8.16%
Price 23.64
S1 22.65 -4.19%
S2 20.41 -13.66%
S3 18.64 -21.15%

FAQ

What is the symbol for Denali Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Denali Therapeutics Inc. is DNLI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Denali Therapeutics Inc. Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

How to buy Denali Therapeutics Inc. Stock?
Denali Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Denali Therapeutics Inc. Stock.

What's the current price of Denali Therapeutics Inc. Stock?
As of the end of day on the Jul 22, 2026, the price of an Denali Therapeutics Inc. (DNLI) share was $23.64.

What is the 52-week high and low for Denali Therapeutics Inc. Stock?
The 52-week high for Denali Therapeutics Inc. Stock is $27.30 and the 52-week low is $12.58.

What is the market capitalization of Denali Therapeutics Inc. Stock?
As of the Jul 22, 2026, the market capitalization of Denali Therapeutics Inc. is 3.752B.

When is the next earnings date for Denali Therapeutics Inc.?
The upcoming earnings date for Denali Therapeutics Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT DENALI THERAPEUTICS INC.
Denali Therapeutics
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for ...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
6.70% Jul 13
JLL
$299.78
8.23% Jun 24
ROP
$331.60
5.76% Jun 24
NMRK
$15.02
4.79% Jun 24
CAG
$13.43
10.69% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE